3.
乳腺癌患者预后多因素生存分析
Multivariate survival analysis of breast cancer patients (n=83)
Group | B | SE | Wald | Sig. | Exp (B) | 95.0%CI for Exp (B) |
JMJD3 | 2.500 | 1.054 | 5.629 | 0.018 | 12.180 | 1.544-96.049 |
MMP2 | -3.053 | 1.095 | 7.767 | 0.005 | 0.047 | 0.006-0.404 |
VEGF | 3.290 | 0.890 | 13.651 | 0.000 | 26.838 | 4.686-153.701 |
Age | 0.878 | 0.543 | 2.612 | 0.106 | 2.407 | 0.830-6.983 |
Position | 0.112 | 0.434 | 0.067 | 0.796 | 1.119 | 0.478-2.618 |
Tumor Maximal diameter | -0.108 | 0.290 | 0.140 | 0.708 | 0.897 | 0.508-1.584 |
Histologic differentiation | 1.088 | 0.267 | 16.595 | 0.000 | 2.968 | 1.759-5.010 |
Lymph node metastasis | -0.343 | 0.416 | 0.680 | 0.410 | 0.710 | 0.314-1.604 |
TNM stage | 0.715 | 0.403 | 3.144 | 0.076 | 2.043 | 0.927-4.503 |